EPO Patents = 1

Forward Citations = 101

Loading Chart...

2 inventors (with patents filed for the assignee):

Dennis Bang Henriksen (4 out of 8 patents)

Jens Juul Holst (3 out of 8 patents)

4 patents: Sort by Forward Citations

1. 7371721 - Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes (2008-05-13),

2. 7186683 - Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders (2007-03-06),

3. 6943151 - Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds (2005-09-13),

4. 6770620 - Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders (2004-08-03),

Sanos Bioscience A/S is a leading biotechnology company focused on developing innovative solutions for the healthcare industry. With a strong emphasis on research and development, we are dedicated to creating cutting-edge products that improve patient outcomes and quality of life. Our team of experts are committed to driving advancements in medical technology and biopharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

4 Patents

#14 in Herlev

#546 in Denmark

Herlev, Denmark

Sanos Bioscience A/s

Forward Citations = 101

2 inventors:

Dennis Bang Henriksen (4 out of 8 patents)

Jens Juul Holst (3 out of 8 patents)

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com